These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 22910893)

  • 21. tPA Mobilizes Immune Cells That Exacerbate Hemorrhagic Transformation in Stroke.
    Shi K; Zou M; Jia DM; Shi S; Yang X; Liu Q; Dong JF; Sheth KN; Wang X; Shi FD
    Circ Res; 2021 Jan; 128(1):62-75. PubMed ID: 33070717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. THR-18, a 18-mer peptide derived from PAI-1, is neuroprotective and improves thrombolysis by tPA in rat stroke models.
    Krakovsky M; Polianski V; Nimrod A; Higazi A; Leker RR; Lamensdorf I
    Neurol Res; 2011 Nov; 33(9):983-90. PubMed ID: 22081002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of tissue plasminogen activator and annexin A2 combination therapy on long-term neurological outcomes of rat focal embolic stroke.
    Wang X; Fan X; Yu Z; Liao Z; Zhao J; Mandeville E; Guo S; Lo EH; Wang X
    Stroke; 2014 Feb; 45(2):619-22. PubMed ID: 24368559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective and safe conditions of low-frequency transcranial ultrasonic thrombolysis for acute ischemic stroke: neurologic and histologic evaluation in a rat middle cerebral artery stroke model.
    Saguchi T; Onoue H; Urashima M; Ishibashi T; Abe T; Furuhata H
    Stroke; 2008 Mar; 39(3):1007-11. PubMed ID: 18239172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of minocycline plus tissue plasminogen activator combination therapy after focal embolic stroke in type 1 diabetic rats.
    Fan X; Lo EH; Wang X
    Stroke; 2013 Mar; 44(3):745-52. PubMed ID: 23422086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The PI3K/Akt pathway mediates the neuroprotective effect of atorvastatin in extending thrombolytic therapy after embolic stroke in the rat.
    Zhang L; Zhang ZG; Liu XS; Hozeska-Solgot A; Chopp M
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2470-5. PubMed ID: 17717296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early insulin glycemic control combined with tPA thrombolysis reduces acute brain tissue damages in a focal embolic stroke model of diabetic rats.
    Fan X; Ning M; Lo EH; Wang X
    Stroke; 2013 Jan; 44(1):255-9. PubMed ID: 23117722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Remote ischemic perconditioning in thrombolysed stroke patients: randomized study of activating endogenous neuroprotection - design and MRI measurements.
    Hougaard KD; Hjort N; Zeidler D; Sørensen L; Nørgaard A; Thomsen RB; Jonsdottir K; Mouridsen K; Hansen TM; Cho TH; Nielsen TT; Bøtker HE; Østergaard L; Andersen G
    Int J Stroke; 2013 Feb; 8(2):141-6. PubMed ID: 22463392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients.
    Alvarez-Sabín J; Molina CA; Montaner J; Arenillas JF; Huertas R; Ribo M; Codina A; Quintana M
    Stroke; 2003 May; 34(5):1235-41. PubMed ID: 12677014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activated protein C analog protects from ischemic stroke and extends the therapeutic window of tissue-type plasminogen activator in aged female mice and hypertensive rats.
    Wang Y; Zhao Z; Chow N; Rajput PS; Griffin JH; Lyden PD; Zlokovic BV
    Stroke; 2013 Dec; 44(12):3529-36. PubMed ID: 24159062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
    Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N
    PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.
    Rubiera M; Alvarez-Sabín J; Ribo M; Montaner J; Santamarina E; Arenillas JF; Huertas R; Delgado P; Purroy F; Molina CA
    Stroke; 2005 Jul; 36(7):1452-6. PubMed ID: 15947260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke.
    Zhang L; Zhang ZG; Zhang R; Morris D; Lu M; Coller BS; Chopp M
    Circulation; 2003 Jun; 107(22):2837-43. PubMed ID: 12756151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke.
    Zhang L; Zhang ZG; Zhang RL; Lu M; Krams M; Chopp M
    Stroke; 2003 Jul; 34(7):1790-5. PubMed ID: 12805500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RiPerC Attenuates Cerebral Ischemia Injury through Regulation of miR-98/PIK3IP1/PI3K/AKT Signaling Pathway.
    Zhang D; Mei L; Long R; Cui C; Sun Y; Wang S; Xia Z
    Oxid Med Cell Longev; 2020; 2020():6454281. PubMed ID: 33082912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual Antiplatelet Therapy Increases Hemorrhagic Transformation Following Thrombolytic Treatment in Experimental Stroke.
    Zheng Y; Lieschke F; Schaefer JH; Wang X; Foerch C; van Leyen K
    Stroke; 2019 Dec; 50(12):3650-3653. PubMed ID: 31587659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination treatment with low-dose Niaspan and tissue plasminogen activator provides neuroprotection after embolic stroke in rats.
    Shehadah A; Chen J; Cui Y; Zhang L; Roberts C; Lu M; Chopp M
    J Neurol Sci; 2011 Oct; 309(1-2):96-101. PubMed ID: 21802695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy with normobaric oxygen (NBO) plus thrombolysis in experimental ischemic stroke.
    Fujiwara N; Murata Y; Arai K; Egi Y; Lu J; Wu O; Singhal AB; Lo EH
    BMC Neurosci; 2009 Jul; 10():79. PubMed ID: 19604385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 hours.
    Röther J; Schellinger PD; Gass A; Siebler M; Villringer A; Fiebach JB; Fiehler J; Jansen O; Kucinski T; Schoder V; Szabo K; Junge-Hülsing GJ; Hennerici M; Zeumer H; Sartor K; Weiller C; Hacke W;
    Stroke; 2002 Oct; 33(10):2438-45. PubMed ID: 12364735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.